<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>316</number>
    <updateDate>2023-01-11T20:05:30Z</updateDate>
    <updateDateIncludingText>2023-01-11T20:05:30Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2007-01-17</introducedDate>
    <congress>110</congress>
    <committees>
      <item>
        <systemCode>ssju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>ssju01</systemCode>
            <name>Competition Policy, Antitrust, and Consumer Rights Subcommittee</name>
            <activities>
              <item>
                <name>Hearings by</name>
                <date>2007-03-07T22:55:24Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2007-02-27T20:43:19Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2007-02-15T17:45:33Z</date>
          </item>
          <item>
            <name>Hearings by</name>
            <date>2007-01-18T00:25:25Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2007-01-17T19:56:38Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Preserve Access to Affordable Generics Act</title>
        <congress>110</congress>
        <number>1432</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2007-03-12</actionDate>
          <text>Referred to the Subcommittee on Commerce, Trade and Consumer Protection.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2007-03-07</actionDate>
        <committees>
          <item>
            <systemCode>ssju01</systemCode>
            <name>Competition Policy, Antitrust, and Consumer Rights Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2007-02-27</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 59.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2007-02-27</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Reported by Senator Leahy without amendment. Without written report.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2007-02-27</actionDate>
        <text>Committee on the Judiciary. Reported by Senator Leahy without amendment. Without written report.</text>
        <type>Committee</type>
        <actionCode>14000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2007-02-15</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Approved for reporting without amendment favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2007-01-17</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Hearings held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2007-01-17</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S679-680)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2007-01-17</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S679)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2007-01-17</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>K000305</bioguideId>
        <fullName>Sen. Kohl, Herb [D-WI]</fullName>
        <firstName>HERBERT</firstName>
        <lastName>KOHL</lastName>
        <party>D</party>
        <state>WI</state>
        <middleName>H.</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>G000386</bioguideId>
        <fullName>Sen. Grassley, Chuck [R-IA]</fullName>
        <firstName>Charles</firstName>
        <lastName>Grassley</lastName>
        <party>R</party>
        <state>IA</state>
        <middleName>E.</middleName>
        <sponsorshipDate>2007-01-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000174</bioguideId>
        <fullName>Sen. Leahy, Patrick J. [D-VT]</fullName>
        <firstName>Patrick</firstName>
        <lastName>Leahy</lastName>
        <party>D</party>
        <state>VT</state>
        <sponsorshipDate>2007-01-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000148</bioguideId>
        <fullName>Sen. Schumer, Charles E. [D-NY]</fullName>
        <firstName>Charles</firstName>
        <lastName>Schumer</lastName>
        <party>D</party>
        <state>NY</state>
        <middleName>E.</middleName>
        <sponsorshipDate>2007-01-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>F000061</bioguideId>
        <fullName>Sen. Feingold, Russell D. [D-WI]</fullName>
        <firstName>RUSSELL</firstName>
        <lastName>FEINGOLD</lastName>
        <party>D</party>
        <state>WI</state>
        <middleName>D.</middleName>
        <sponsorshipDate>2007-01-17</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>K000105</bioguideId>
        <fullName>Sen. Kennedy, Edward M. [D-MA]</fullName>
        <firstName>EDWARD</firstName>
        <lastName>KENNEDY</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>MOORE</middleName>
        <sponsorshipDate>2007-02-14</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>Richard</firstName>
        <lastName>Durbin</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>J.</middleName>
        <sponsorshipDate>2007-02-27</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>J000177</bioguideId>
        <fullName>Sen. Johnson, Tim [D-SD]</fullName>
        <firstName>TIM</firstName>
        <lastName>JOHNSON</lastName>
        <party>D</party>
        <state>SD</state>
        <sponsorshipDate>2007-04-11</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>O000167</bioguideId>
        <fullName>Sen. Obama, Barack [D-IL]</fullName>
        <firstName>Barack</firstName>
        <lastName>Obama</lastName>
        <party>D</party>
        <state>IL</state>
        <sponsorshipDate>2007-09-12</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B000944</bioguideId>
        <fullName>Sen. Brown, Sherrod [D-OH]</fullName>
        <firstName>Sherrod</firstName>
        <lastName>Brown</lastName>
        <party>D</party>
        <state>OH</state>
        <sponsorshipDate>2007-12-18</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>K000367</bioguideId>
        <fullName>Sen. Klobuchar, Amy [D-MN]</fullName>
        <firstName>Amy</firstName>
        <lastName>Klobuchar</lastName>
        <party>D</party>
        <state>MN</state>
        <sponsorshipDate>2008-09-08</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Commerce</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Antitrust law</name>
        </item>
        <item>
          <name>Competition</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Crime and Law Enforcement</name>
        </item>
        <item>
          <name>Criminal investigation</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Generic drugs</name>
        </item>
        <item>
          <name>Governmental investigations</name>
        </item>
        <item>
          <name>Health</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Marketing</name>
        </item>
        <item>
          <name>Patent infringement</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Restrictive trade practices</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Commerce</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2007-01-17</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2007-03-15T20:19:17Z</updateDate>
        <text><![CDATA[ <p>Preserve Access to Affordable Generics Act - Amends the Clayton Act to make it unlawful for a person, in connection with the sale of a drug product, to be a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market, or sell the generic product for any period. Excludes a resolution or settlement that includes no more than the right to market the generic product prior to the expiration of the patent.</p> <p>Amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to set forth additional filing requirements related to agreements between a brand name drug company and a generic drug applicant. Requires the Chief Executive Officer or the company official responsible for negotiating any agreement to file a certification that materials filed with respect to such agreements are complete, final, and exclusive.</p> <p>Amends the Federal Food, Drug, and Cosmetic Act to provide that forfeiture of the 180-day exclusivity period for the marketing of a generic drug occurs if there is a final decision of the Federal Trade Commission (FTC) or the court that an agreement has violated this Act.</p> <p>Requires the FTC to study the prevalence of anticompetitive agreements in the pharmaceutical industry and their impact. Requires the Attorney General or FTC to consider whether any additional enforcement action is necessary.</p>]]></text>
      </summary>
      <summary>
        <versionCode>80</versionCode>
        <actionDate>2007-02-27</actionDate>
        <actionDesc>Reported to Senate without amendment</actionDesc>
        <updateDate>2007-04-27T18:05:20Z</updateDate>
        <text><![CDATA[ <p><b>(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)</b></p> <p>Preserve Access to Affordable Generics Act - Amends the Clayton Act to make it unlawful for a person, in connection with the sale of a drug product, to be a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market, or sell the generic product for any period. Excludes a resolution or settlement that includes no more than the right to market the generic product prior to the expiration of the patent.</p> <p>Amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to set forth additional filing requirements related to agreements between a brand name drug company and a generic drug applicant. Requires the Chief Executive Officer or the company official responsible for negotiating any agreement to file a certification that materials filed with respect to such agreements: (1) are complete, final, and exclusive; (2) include any ancillary agreements that are contingent upon, provide a contingent condition for, or are otherwise related to, the agreement; and (3) include written descriptions of any relevant oral agreements, representations, commitments, or promises between the parties that have not been reduced to writing.</p> <p>Amends the Federal Food, Drug, and Cosmetic Act to provide that forfeiture of the 180-day exclusivity period for the marketing of a generic drug occurs if there is a final decision of the Federal Trade Commission (FTC) or the court that an agreement has violated this Act.</p> <p>Requires the FTC to study the prevalence of anticompetitive agreements in the pharmaceutical industry and their impact. Requires the Attorney General or FTC to consider whether any additional enforcement action is necessary.</p> <p>Authorizes appropriations.</p>]]></text>
      </summary>
    </summaries>
    <title>Preserve Access to Affordable Generics Act</title>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>Preserve Access to Affordable Generics Act</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Preserve Access to Affordable Generics Act</title>
      </item>
      <item>
        <titleType>Short Titles as Reported to Senate</titleType>
        <title>Preserve Access to Affordable Generics Act</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Reported to Senate</type>
        <date>2007-02-27T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110s316rs/xml/BILLS-110s316rs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in Senate</type>
        <date>2007-01-17T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110s316is/xml/BILLS-110s316is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2007-03-07</actionDate>
      <text>Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
